Quarterly
Annual
| Unit: USD | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
operating activities | ||||||||||||||||||||||||||||||||
net income | 69,000,000 | 77,000,000 | 91,000,000 | 101,000,000 | 22,000,000 | 33,000,000 | 126,000,000 | 91,000,000 | 48,000,000 | 55,000,000 | 46,000,000 | 63,000,000 | 29,000,000 | 51,000,000 | 58,000,000 | 54,000,000 | 66,476,000 | 42,836,000 | 39,951,000 | 28,737,000 | 22,966,000 | 14,581,000 | 12,282,000 | 11,577,000 | 14,095,000 | 3,097,000 | -1,308,000 | 15,811,000 | 7,011,000 | 725,000 | 6,221,000 | 1,540,000 |
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||||||||||||||
depreciation and amortization of intangible assets | ||||||||||||||||||||||||||||||||
amortization of deferred costs | ||||||||||||||||||||||||||||||||
amortization of rou asset, lease modification, impairment, and abandonment | ||||||||||||||||||||||||||||||||
stock based compensation | 13,000,000 | 13,000,000 | 13,000,000 | 11,000,000 | 12,000,000 | 11,000,000 | 11,000,000 | 9,000,000 | 12,000,000 | |||||||||||||||||||||||
accretion of discount rate on lease liabilities | 0 | 1,000,000 | 0 | 1,000,000 | 0 | 1,000,000 | ||||||||||||||||||||||||||
benefit from doubtful accounts | ||||||||||||||||||||||||||||||||
deferred income taxes | 42,118,000 | 13,119,000 | -142,000 | 16,662,000 | 24,904,000 | 864,000 | 1,412,000 | |||||||||||||||||||||||||
losses from disposition of assets | ||||||||||||||||||||||||||||||||
losses and impairment on investments | ||||||||||||||||||||||||||||||||
impairment of intangibles | ||||||||||||||||||||||||||||||||
changes in operating assets and liabilities: | ||||||||||||||||||||||||||||||||
accounts receivable | -7,000,000 | 0 | -3,000,000 | 13,000,000 | -12,000,000 | 1,000,000 | 0 | 2,000,000 | 2,000,000 | 1,000,000 | ||||||||||||||||||||||
prepaid expenses | 5,000,000 | -5,000,000 | -10,000,000 | 5,000,000 | -11,000,000 | -3,000,000 | 5,000,000 | -3,000,000 | 12,000,000 | 1,000,000 | -6,000,000 | -12,000,000 | ||||||||||||||||||||
other payroll assets | ||||||||||||||||||||||||||||||||
accounts payable and other current liabilities | 14,000,000 | -10,000,000 | -4,000,000 | 33,000,000 | 9,000,000 | -59,000,000 | 40,000,000 | 29,000,000 | 1,000,000 | -5,000,000 | -20,000,000 | 9,000,000 | 1,000,000 | 5,000,000 | 1,000,000 | -15,000,000 | ||||||||||||||||
client deposits and other client liabilities | -23,000,000 | -12,000,000 | -19,000,000 | 17,000,000 | -76,000,000 | 61,000,000 | ||||||||||||||||||||||||||
accrued wages | -186,000,000 | 49,000,000 | 18,000,000 | 179,000,000 | -145,000,000 | 43,000,000 | -18,000,000 | 38,000,000 | -13,000,000 | 28,000,000 | 8,000,000 | 17,000,000 | ||||||||||||||||||||
accrued health insurance costs | 12,000,000 | 7,000,000 | -10,000,000 | -7,000,000 | 12,000,000 | 15,000,000 | -20,000,000 | -2,000,000 | 11,000,000 | 12,000,000 | ||||||||||||||||||||||
accrued workers' compensation costs | -1,000,000 | 1,000,000 | -7,000,000 | 0 | -5,000,000 | 3,000,000 | -4,000,000 | -3,000,000 | -11,000,000 | -2,000,000 | ||||||||||||||||||||||
payroll taxes payable and other payroll withholdings | 362,000,000 | -5,000,000 | -97,000,000 | -426,000,000 | 661,000,000 | 8,000,000 | -141,000,000 | -334,000,000 | 512,000,000 | -84,000,000 | -76,000,000 | -180,000,000 | ||||||||||||||||||||
operating lease liabilities | -3,000,000 | -4,000,000 | -3,000,000 | -3,000,000 | -4,000,000 | -5,000,000 | -5,000,000 | -5,000,000 | -4,000,000 | -4,000,000 | -5,000,000 | -4,000,000 | ||||||||||||||||||||
other assets | -16,000,000 | -2,000,000 | -8,000,000 | -24,000,000 | 8,000,000 | -14,000,000 | -4,000,000 | -28,000,000 | 0 | -4,000,000 | 0 | -30,000,000 | -2,000,000 | 3,075,000 | 834,000 | -57,000 | 148,000 | -176,000 | 200,000 | 550,000 | -312,000 | 58,000 | -162,000 | 3,295,000 | 838,000 | 4,033,000 | ||||||
other liabilities | 1,000,000 | 0 | 1,000,000 | -4,000,000 | 8,000,000 | 0 | 1,000,000 | 2,000,000 | 1,000,000 | -11,000,000 | 1,000,000 | -3,000,000 | 15,205,000 | -15,936,000 | 21,887,000 | 16,422,000 | 9,110,000 | 7,926,000 | 10,451,000 | 6,876,000 | 4,869,000 | |||||||||||
net cash from operating activities | 234,000,000 | 174,000,000 | -15,000,000 | -175,000,000 | 586,000,000 | 90,000,000 | 152,000,000 | -282,000,000 | 682,000,000 | -49,000,000 | -20,000,000 | -142,000,000 | 372,000,000 | 67,000,000 | -7,000,000 | -536,000,000 | 94,049,000 | 54,838,000 | 28,209,000 | 75,904,000 | 66,424,000 | 35,144,000 | 2,066,000 | 40,898,000 | 26,078,000 | 59,343,000 | 31,060,000 | 14,118,000 | 54,857,000 | 45,324,000 | 23,320,000 | 30,337,000 |
capex | -11,000,000 | -11,000,000 | -13,000,000 | -2,000,000 | -8,000,000 | -10,000,000 | -11,000,000 | -5,000,000 | -13,000,000 | -13,000,000 | -10,000,000 | -7,000,000 | -9,000,000 | -7,000,000 | -14,000,000 | -10,000,000 | -450,000 | -7,615,000 | -10,643,000 | -8,502,000 | -12,248,000 | -11,446,000 | -9,761,000 | -5,372,000 | -3,534,000 | -48,000 | -918,000 | 1,034,000 | 464,000 | -3,144,000 | 3,338,000 | 632,000 |
free cash flows | 223,000,000 | 163,000,000 | -28,000,000 | -177,000,000 | 578,000,000 | 80,000,000 | 141,000,000 | -287,000,000 | 669,000,000 | -62,000,000 | -30,000,000 | -149,000,000 | 363,000,000 | 60,000,000 | -21,000,000 | -546,000,000 | 93,599,000 | 47,223,000 | 17,566,000 | 67,402,000 | 54,176,000 | 23,698,000 | -7,695,000 | 35,526,000 | 22,544,000 | 59,295,000 | 30,142,000 | 15,152,000 | 55,321,000 | 42,180,000 | 26,658,000 | 30,969,000 |
investing activities | ||||||||||||||||||||||||||||||||
purchases of marketable securities | -96,000,000 | -81,000,000 | -185,000,000 | -82,000,000 | -49,000,000 | -56,000,000 | -67,000,000 | -155,000,000 | -193,000,000 | -44,000,000 | -35,000,000 | -30,000,000 | -35,000,000 | -20,000,000 | ||||||||||||||||||
proceeds from sale and maturity of marketable securities | 117,000,000 | 83,000,000 | 65,000,000 | 84,000,000 | 46,000,000 | 48,000,000 | 34,000,000 | 31,000,000 | ||||||||||||||||||||||||
acquisitions of property and equipment and projects in process | ||||||||||||||||||||||||||||||||
acquisitions of subsidiaries, net of cash acquired | ||||||||||||||||||||||||||||||||
other investments | ||||||||||||||||||||||||||||||||
net cash from investing activities | 10,000,000 | -10,000,000 | -132,000,000 | -3,000,000 | 0 | -30,000,000 | -27,000,000 | -94,000,000 | -158,000,000 | -5,000,000 | -14,000,000 | -11,000,000 | -31,000,000 | -3,000,000 | -168,000,000 | 2,000,000 | -9,237,000 | -5,507,000 | -2,408,000 | -6,848,000 | -9,711,000 | -10,436,000 | -1,368,000 | -5,607,000 | -4,478,000 | |||||||
financing activities | ||||||||||||||||||||||||||||||||
change in wse and trinet trust related assets and liabilities | ||||||||||||||||||||||||||||||||
repurchase of common stock | 0 | -20,000,000 | -14,000,000 | -60,000,000 | -43,000,000 | -35,000,000 | -60,000,000 | -40,000,000 | -56,000,000 | -22,000,000 | -24,000,000 | -38,000,000 | -14,000,000 | -17,000,000 | -22,000,000 | -8,000,000 | -4,653,000 | -9,837,000 | -1,915,000 | -27,595,000 | -27,857,000 | -27,288,000 | 576,000 | |||||||||
proceeds from issuance of common stock | 5,000,000 | 1,000,000 | 5,000,000 | 0 | 1,000,000 | 218,859,000 | ||||||||||||||||||||||||||
payment of long-term financing costs and debt issuance costs | ||||||||||||||||||||||||||||||||
proceeds from issuance of 2031 notes | ||||||||||||||||||||||||||||||||
proceeds from revolving credit agreement borrowings | 0 | 0 | 0 | 234,000,000 | ||||||||||||||||||||||||||||
repayment of borrowings under revolving credit agreement | ||||||||||||||||||||||||||||||||
awards effectively repurchased for required employee withholding taxes | -13,000,000 | -4,000,000 | -4,000,000 | -5,000,000 | -7,000,000 | -5,000,000 | -3,000,000 | -3,000,000 | -11,000,000 | -4,000,000 | -6,000,000 | -4,000,000 | -7,000,000 | -5,000,000 | -6,000,000 | -4,000,000 | -2,900,000 | -3,593,000 | -2,520,000 | -1,987,000 | -1,473,000 | -1,187,000 | -829,000 | -656,000 | ||||||||
dividends paid | ||||||||||||||||||||||||||||||||
net cash from financing activities | -8,000,000 | -23,000,000 | -13,000,000 | 56,000,000 | -285,000,000 | -45,000,000 | -63,000,000 | 185,000,000 | -67,000,000 | -32,000,000 | -30,000,000 | -47,000,000 | -23,000,000 | -26,000,000 | -17,000,000 | -19,000,000 | -11,937,000 | -19,922,000 | -8,089,000 | -37,052,000 | -32,964,000 | -30,880,000 | -29,836,000 | -5,691,000 | -1,655,000 | 4,014,000 | ||||||
effect of exchange rate changes on cash and cash equivalents | 235,000 | 117,000 | 46,000 | -303,000 | 66,000 | -136,000 | 160,000 | -82,000 | ||||||||||||||||||||||||
net increase in cash and cash equivalents, unrestricted and restricted | -553,000,000 | |||||||||||||||||||||||||||||||
cash and cash equivalents, unrestricted and restricted: | ||||||||||||||||||||||||||||||||
beginning of period | 0 | 0 | 0 | 1,643,000,000 | 0 | 0 | 0 | 1,456,000,000 | 0 | 0 | 0 | 1,349,000,000 | 0 | 0 | 0 | 1,738,000,000 | ||||||||||||||||
end of period | 236,000,000 | 141,000,000 | -160,000,000 | 1,521,000,000 | 301,000,000 | 15,000,000 | 62,000,000 | 1,265,000,000 | 457,000,000 | -86,000,000 | -64,000,000 | 1,149,000,000 | 318,000,000 | 38,000,000 | -192,000,000 | 1,185,000,000 | ||||||||||||||||
supplemental disclosures of cash flow information | ||||||||||||||||||||||||||||||||
interest paid | 1,000,000 | 9,000,000 | 0 | 2,000,000 | 5,000,000 | 4,000,000 | 4,000,000 | 3,000,000 | 4,000,000 | 6,000,000 | 5,000,000 | 4,000,000 | 4,000,000 | 5,000,000 | 4,000,000 | 4,000,000 | 3,814,000 | 4,180,000 | 3,844,000 | 4,162,000 | ||||||||||||
income taxes paid | 46,000,000 | 38,000,000 | 43,000,000 | 2,000,000 | 40,000,000 | 77,000,000 | 5,000,000 | 1,000,000 | 14,000,000 | 15,000,000 | 32,000,000 | 1,000,000 | 16,000,000 | 9,000,000 | ||||||||||||||||||
supplemental schedule of noncash investing and financing activities | ||||||||||||||||||||||||||||||||
cash dividend declared, but not yet paid | ||||||||||||||||||||||||||||||||
payable for purchase of property and equipment | 1,000,000 | -1,000,000 | 3,000,000 | 1,000,000 | -1,000,000 | 1,000,000 | 1,000,000 | -2,000,000 | -4,000,000 | 3,000,000 | 5,000,000 | 1,000,000 | 0 | 0 | 2,000,000 | -450,000 | 870,000 | -391,000 | 1,971,000 | -540,000 | -218,000 | 146,000 | 1,435,000 | 276,000 | -48,000 | -918,000 | 1,034,000 | 464,000 | -3,144,000 | 3,338,000 | 632,000 | |
acquisitions of subsidiaries paid in stock | ||||||||||||||||||||||||||||||||
unbilled revenue | -19,000,000 | 41,000,000 | -6,000,000 | -94,000,000 | 129,000,000 | -23,000,000 | 28,000,000 | -95,000,000 | 80,000,000 | -25,000,000 | -27,000,000 | -9,000,000 | ||||||||||||||||||||
proceeds from issuance of 2029 notes | 0 | 0 | 0 | 500,000,000 | ||||||||||||||||||||||||||||
repayment of borrowings | ||||||||||||||||||||||||||||||||
depreciation and amortization | 19,000,000 | 18,000,000 | 26,000,000 | 19,000,000 | 18,000,000 | 17,000,000 | 17,000,000 | 15,000,000 | 16,000,000 | 14,000,000 | 9,000,000 | 18,000,000 | 10,000,000 | 12,000,000 | 14,000,000 | 10,000,000 | 8,823,000 | 9,681,000 | 8,373,000 | 8,123,000 | 11,365,000 | 9,891,000 | 9,173,000 | 8,746,000 | 10,258,000 | 14,257,000 | 13,561,000 | 14,741,000 | 16,649,000 | 28,684,000 | 17,042,000 | 22,028,000 |
amortization of (premium) discount on investments | ||||||||||||||||||||||||||||||||
acquisitions of property and equipment | -11,000,000 | -12,000,000 | -12,000,000 | -5,000,000 | -9,000,000 | -9,000,000 | -12,000,000 | -6,000,000 | -11,000,000 | -9,000,000 | -13,000,000 | -12,000,000 | -10,000,000 | -7,000,000 | -14,000,000 | -12,000,000 | -8,485,000 | -10,252,000 | -10,473,000 | |||||||||||||
payment of long-term financing costs | ||||||||||||||||||||||||||||||||
draw down from revolving credit facility | ||||||||||||||||||||||||||||||||
repayment of borrowings under revolving credit facility | ||||||||||||||||||||||||||||||||
amortization of rou asset, lease modification and impairment | ||||||||||||||||||||||||||||||||
other | 0 | |||||||||||||||||||||||||||||||
payment of debt issuance costs | 0 | 0 | 0 | -7,000,000 | 0 | |||||||||||||||||||||||||||
amortization of rou | 2,000,000 | 3,000,000 | 3,000,000 | 4,000,000 | ||||||||||||||||||||||||||||
lease modification and impairment | ||||||||||||||||||||||||||||||||
amortization of premium of investments | 1,000,000 | 0 | 1,000,000 | |||||||||||||||||||||||||||||
payment of long-term financing fees | 0 | 0 | -2,000,000 | |||||||||||||||||||||||||||||
repayment of debt | 0 | 0 | -370,000,000 | -6,000,000 | -5,000,000 | -5,000,000 | -6,000,000 | -5,000,000 | -6,000,000 | -5,000,000 | -6,000,000 | |||||||||||||||||||||
net decrease in cash and cash equivalents, unrestricted and restricted | 141,000,000 | -160,000,000 | -122,000,000 | 15,000,000 | 62,000,000 | -191,000,000 | 38,000,000 | |||||||||||||||||||||||||
amortization of rou asset | ||||||||||||||||||||||||||||||||
amortization of (premium) discount of investments | ||||||||||||||||||||||||||||||||
proceeds from issuance of notes payable | 0 | 0 | ||||||||||||||||||||||||||||||
payments for extinguishment of debt | 0 | 0 | 0 | |||||||||||||||||||||||||||||
proceeds from sales and maturities of marketable securities | 47,000,000 | 52,000,000 | 67,000,000 | |||||||||||||||||||||||||||||
noncash lease expense | 4,000,000 | 2,000,000 | 4,000,000 | |||||||||||||||||||||||||||||
client deposits | -6,000,000 | 16,000,000 | -38,000,000 | 29,000,000 | -19,000,000 | |||||||||||||||||||||||||||
proceeds from issuance of common stock from employee stock purchase plan | 0 | |||||||||||||||||||||||||||||||
proceeds from issuance of common stock from exercised options | 0 | |||||||||||||||||||||||||||||||
net decrease in unrestricted and restricted cash and cash equivalents | -86,000,000 | -64,000,000 | -200,000,000 | |||||||||||||||||||||||||||||
stock-based compensation | 11,000,000 | 9,000,000 | 13,000,000 | 12,000,000 | 10,000,000 | 9,000,000 | 10,594,000 | 7,700,000 | 7,499,000 | 6,207,000 | 6,328,000 | 6,264,000 | 6,508,000 | 7,397,000 | 4,932,000 | 4,188,000 | 4,883,000 | 3,920,000 | 2,409,000 | 3,181,000 | 2,923,000 | 2,147,000 | ||||||||||
proceeds from issuance of debt | ||||||||||||||||||||||||||||||||
net increase in unrestricted and restricted cash and cash equivalents | ||||||||||||||||||||||||||||||||
prepaid income taxes | -1,000,000 | -11,000,000 | 13,000,000 | -5,448,000 | 14,783,000 | 12,867,000 | 14,798,000 | -38,101,000 | 3,249,000 | -3,080,000 | 3,621,000 | |||||||||||||||||||||
prepaid expenses and other current assets | -1,000,000 | -14,000,000 | -9,000,000 | 1,961,000 | 1,640,000 | -4,302,000 | 1,701,000 | 2,262,000 | -220,000 | -3,876,000 | -1,157,000 | 4,514,000 | ||||||||||||||||||||
workers' compensation collateral receivable and other noncurrent assets | -4,000,000 | |||||||||||||||||||||||||||||||
accrued corporate wages | 1,000,000 | 4,000,000 | -9,000,000 | |||||||||||||||||||||||||||||
workers' compensation loss reserves and other noncurrent liabilities | ||||||||||||||||||||||||||||||||
worksite employee related assets | -55,000,000 | 18,000,000 | -14,000,000 | -683,767,000 | -42,108,000 | 140,753,000 | 242,122,000 | -433,926,000 | 100,026,000 | 79,252,000 | 346,563,000 | -506,260,000 | -28,887,000 | 84,380,000 | 712,517,000 | -32,768,000 | -479,000 | 108,637,000 | ||||||||||||||
worksite employee related liabilities | 43,000,000 | -86,000,000 | -566,000,000 | 683,127,000 | 41,758,000 | -140,983,000 | -241,902,000 | 433,443,000 | -100,851,000 | -79,055,000 | -347,039,000 | 507,494,000 | ||||||||||||||||||||
proceeds from sale of marketable securities | 15,000,000 | |||||||||||||||||||||||||||||||
proceeds from maturity of marketable securities | 9,000,000 | 10,000,000 | 14,000,000 | -447,000 | 2,978,000 | 7,844,000 | 3,625,000 | |||||||||||||||||||||||||
proceeds from issuance of common stock on exercised options | 1,000,000 | 2,000,000 | 3,000,000 | 2,322,000 | 3,092,000 | 3,487,000 | 2,099,000 | 1,688,000 | 1,364,000 | 1,716,000 | 504,000 | 702,000 | 1,825,000 | 1,440,000 | 3,199,000 | 1,047,000 | 515,000 | 137,000 | 494,000 | |||||||||||||
proceeds from issuance of common stock on employee stock purchase plan | 0 | 2,559,000 | 0 | 2,202,000 | 0 | 2,592,000 | 0 | |||||||||||||||||||||||||
repayment of notes payable | -5,000,000 | 0 | -10,000,000 | -5,062,000 | -5,063,000 | |||||||||||||||||||||||||||
supplemental schedule of cash and cash equivalents | ||||||||||||||||||||||||||||||||
net increase in unrestricted cash and cash equivalents | 35,000,000 | -128,000,000 | -6,000,000 | |||||||||||||||||||||||||||||
net decrease in restricted cash and cash equivalents | 3,000,000 | |||||||||||||||||||||||||||||||
workers' compensation collateral receivable | -1,000,000 | 1,048,000 | -12,868,000 | 7,692,000 | -2,872,000 | |||||||||||||||||||||||||||
workers' compensation loss reserves and other non-current liabilities | -6,000,000 | 8,426,000 | 8,635,000 | -13,290,000 | 8,229,000 | |||||||||||||||||||||||||||
income taxes paid (refunded) | 31,000 | 395,000 | -564,000 | |||||||||||||||||||||||||||||
net increase in restricted cash and cash equivalents | -547,000,000 | |||||||||||||||||||||||||||||||
accretion of workers' compensation and leases fair value adjustment | ||||||||||||||||||||||||||||||||
restricted cash and cash equivalents | -430,000 | -13,588,000 | -31,105,000 | -877,000 | ||||||||||||||||||||||||||||
accounts payable | 16,495,000 | 1,503,000 | 4,415,000 | -413,000 | 4,620,000 | 2,050,000 | -3,623,000 | 6,111,000 | -2,235,000 | 386,000 | 1,421,000 | 1,327,000 | 2,078,000 | |||||||||||||||||||
accrued corporate wages and other current liabilities | 8,669,000 | -5,968,000 | -3,604,000 | 11,903,000 | -1,301,000 | 5,267,000 | ||||||||||||||||||||||||||
acquisitions of businesses | 0 | 0 | 0 | -300,000 | 0 | |||||||||||||||||||||||||||
purchase of property and equipment | -11,708,000 | -11,228,000 | -9,907,000 | -6,807,000 | -3,810,000 | |||||||||||||||||||||||||||
tax credit received for deductible ipo transaction costs | ||||||||||||||||||||||||||||||||
net increase in cash and cash equivalents | 72,477,000 | 29,644,000 | 17,829,000 | 32,050,000 | 23,446,000 | -6,106,000 | -29,274,000 | 29,760,000 | 19,863,000 | 36,389,000 | -2,336,000 | -22,313,000 | 28,245,000 | |||||||||||||||||||
cash and cash equivalents at beginning of year | 94,356,000 | |||||||||||||||||||||||||||||||
cash and cash equivalents at end of year | 122,601,000 | |||||||||||||||||||||||||||||||
income taxes paid (refund) | ||||||||||||||||||||||||||||||||
allowance for tenant improvements | ||||||||||||||||||||||||||||||||
repayment of notes and capital leases payable | -9,584,000 | -9,582,000 | -9,569,000 | |||||||||||||||||||||||||||||
cash and cash equivalents at beginning of period | 0 | 0 | 184,004,000 | 0 | 0 | 0 | 166,178,000 | 0 | 0 | 0 | 134,341,000 | 0 | 0 | |||||||||||||||||||
cash and cash equivalents at end of period | 29,644,000 | 17,829,000 | 216,054,000 | 23,446,000 | -6,106,000 | -29,274,000 | 195,938,000 | 19,863,000 | 17,902,000 | 24,012,000 | 104,401,000 | 36,389,000 | -2,336,000 | |||||||||||||||||||
excess tax benefits received from equity incentive plan activity | ||||||||||||||||||||||||||||||||
workers' compensation loss reserves | ||||||||||||||||||||||||||||||||
proceeds from issuance of common stock, net of issuance costs | -776,000 | -41,000 | ||||||||||||||||||||||||||||||
excess tax credits received from equity incentive plan activity | ||||||||||||||||||||||||||||||||
restricted cash and available for sale investments | ||||||||||||||||||||||||||||||||
workers compensation receivables | -775,000 | -2,911,000 | -7,688,000 | -142,000 | 3,379,000 | |||||||||||||||||||||||||||
workers compensation and other liabilities | 8,064,000 | |||||||||||||||||||||||||||||||
purchases of restricted investments | 0 | |||||||||||||||||||||||||||||||
proceeds from maturities of restricted investments | 792,000 | |||||||||||||||||||||||||||||||
repayment of notes payable and capital leases | ||||||||||||||||||||||||||||||||
cash paid for interest | 3,560,000 | 4,008,000 | 4,083,000 | 3,846,000 | 3,572,000 | 6,389,000 | 2,255,000 | 14,314,000 | 9,093,000 | |||||||||||||||||||||||
cash paid for income taxes | 6,276,000 | 18,802,000 | 2,572,000 | 538,000 | -38,000 | |||||||||||||||||||||||||||
excess tax benefit from equity incentive plan activity | -343,000 | -38,000,000 | 4,820,000 | 12,853,000 | 1,276,000 | 1,753,000 | ||||||||||||||||||||||||||
restricted cash and investments | -17,839,000 | -3,202,000 | 3,207,000 | |||||||||||||||||||||||||||||
repayment of notes payable and borrowings under capital leases | ||||||||||||||||||||||||||||||||
excess tax (benefit) deficiency from equity incentive plan activity | 467,000 | |||||||||||||||||||||||||||||||
income taxes payable/receivable | 6,735,000 | |||||||||||||||||||||||||||||||
other current liabilities | -2,505,000 | -3,487,000 | -3,572,000 | 1,532,000 | ||||||||||||||||||||||||||||
maturity of debt securities | 1,500,000 | |||||||||||||||||||||||||||||||
excess tax benefit (deficiency) from equity incentive plan activity | -467,000 | |||||||||||||||||||||||||||||||
repayments under capital leases | -10,000 | -6,000 | ||||||||||||||||||||||||||||||
accretion of workers compensation and leases fair value adjustment | -116,000 | |||||||||||||||||||||||||||||||
purchase of debt securities | -26,950,000 | |||||||||||||||||||||||||||||||
proceeds from maturity of debt securities | 26,282,000 | |||||||||||||||||||||||||||||||
realized tax benefit of deductible ipo transaction costs | 0 | |||||||||||||||||||||||||||||||
borrowings under notes payable | ||||||||||||||||||||||||||||||||
payments of special dividend | ||||||||||||||||||||||||||||||||
restricted cash | ||||||||||||||||||||||||||||||||
income tax payable/receivable | 29,153,000 | |||||||||||||||||||||||||||||||
cash received (paid) for income taxes | 4,357,000 | |||||||||||||||||||||||||||||||
acquisition of businesses | ||||||||||||||||||||||||||||||||
proceeds from sale and maturity of debt securities | ||||||||||||||||||||||||||||||||
proceeds from issuance of common stock for employee stock purchase plan | ||||||||||||||||||||||||||||||||
cash paid for income taxes, net of refunds | -98,000 | 6,715,000 | 4,352,000 | |||||||||||||||||||||||||||||
borrowings under capital leases | 47,000 | |||||||||||||||||||||||||||||||
special dividend payable on unvested restricted stock units | 35,000 |
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
